NUNZIA PHARMACEUTICAL Co Annual Operating Income (Loss) in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NUNZIA PHARMACEUTICAL Co quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2021.
  • NUNZIA PHARMACEUTICAL Co Operating Income (Loss) for the quarter ending September 30, 2022 was -$227K, a 559% decline year-over-year.
  • NUNZIA PHARMACEUTICAL Co annual Operating Income (Loss) for 2021 was -$78.1M.
  • NUNZIA PHARMACEUTICAL Co annual Operating Income (Loss) for 2020 was -$39.3K, a 16.9% decline from 2019.
  • NUNZIA PHARMACEUTICAL Co annual Operating Income (Loss) for 2019 was -$33.6K, a 23.8% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$78.1M* -$78M Jan 1, 2021 Dec 31, 2021 10-K 2022-04-15
2020 -$39.3K -$5.69K -16.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 -$33.6K -$6.46K -23.8% Jan 1, 2019 Dec 31, 2019 10-K/A 2022-03-29
2018 -$27.2K -$14.1K -108% Jan 1, 2018 Dec 31, 2018 10-K 2019-05-31
2017 -$13K Jan 1, 2017 Dec 31, 2017 10-K 2019-05-31
2015 -$750 +$28K +97.4% Jan 1, 2015 Dec 31, 2015 10-K 2019-05-31
2014 -$28.7K +$22.00 +0.08% Jan 1, 2014 Dec 31, 2014 10-K 2019-05-31
2013 -$28.7K -$21.3K -287% Jan 1, 2013 Dec 31, 2013 10-K 2019-05-31
2012 -$7.42K +$23.2K +75.8% Jan 1, 2012 Dec 31, 2012 10-K 2019-05-31
2011 -$30.7K +$40.7K +57% Jan 1, 2011 Dec 31, 2011 10-K 2019-05-31
2010 -$71.3K Jan 1, 2010 Dec 31, 2010 10-K 2019-05-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.